These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 6112181)

  • 1. Altered ability of the liver to produce glucose following a period of glucagon deficiency.
    Deri JJ; Williams PE; Steiner KE; Cherrington AD
    Diabetes; 1981 Jun; 30(6):490-5. PubMed ID: 6112181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential time course of glucagon's effect on glycogenolysis and gluconeogenesis in the conscious dog.
    Cherrington AD; Williams PE; Shulman GI; Lacy WW
    Diabetes; 1981 Mar; 30(3):180-7. PubMed ID: 6110598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restoration of stable metabolic conditions during islet suppression in dogs.
    Bradley DC; Bergman RN
    Am J Physiol; 1992 Apr; 262(4 Pt 1):E532-8. PubMed ID: 1348903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of somatostatin on the hepatic extraction of insulin and glucagon in the anesthetized dog.
    Ishida T; Röjdmark S; Bloom G; Chou MC; Field JB
    Endocrinology; 1980 Jan; 106(1):220-30. PubMed ID: 7349954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of effect of somatostatin on epinephrine-stimulated glucose production in the dog.
    Stevenson RW; Steiner KE; Williams PE; Cherrington AD
    Metabolism; 1987 May; 36(5):451-7. PubMed ID: 2883556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Control of hepatic glucose output by glucagon and insulin in the intact dog.
    Cherrington AD; Chiasson JL; Liljenquist JE; Lacy WW; Park CR
    Biochem Soc Symp; 1978; (43):31-45. PubMed ID: 373768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of insulin and glucagon in the regulation of basal glucose production in the postabsorptive dog.
    Cherrington AD; Chiasson JL; Liljenquist JE; Jennings AS; Keller U; Lacy WW
    J Clin Invest; 1976 Dec; 58(6):1407-18. PubMed ID: 993351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Similar dose responsiveness of hepatic glycogenolysis and gluconeogenesis to glucagon in vivo.
    Stevenson RW; Steiner KE; Davis MA; Hendrick GK; Williams PE; Lacy WW; Brown L; Donahue P; Lacy DB; Cherrington AD
    Diabetes; 1987 Mar; 36(3):382-9. PubMed ID: 2879758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Failure of somatostatin to modify effect of glucagon on carbohydrate metabolism in the dog.
    Cherrington AD; Lacy WW; Williams PE; Steiner KE
    Am J Physiol; 1983 Jun; 244(6):E596-602. PubMed ID: 6134474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of somatostatin, glucagon, and insulin on hepatic glucose output in the normal dog.
    Altszuler N; Gottlieb B; Hampshire J
    Diabetes; 1976 Feb; 25(2):116-21. PubMed ID: 1248672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucose disposal during insulinopenia in somatostatin-treated dogs. The roles of glucose and glucagon.
    Shulman GI; Liljenquist JE; Williams PE; Lacy WW; Cherrington AD
    J Clin Invest; 1978 Aug; 62(2):487-91. PubMed ID: 670404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Importance of basal glucagon in maintaining hepatic glucose production during a prolonged fast in conscious dogs.
    Hendrick GK; Wasserman DH; Frizzell RT; Williams PE; Lacy DB; Jaspan JB; Cherrington AD
    Am J Physiol; 1992 Sep; 263(3 Pt 1):E541-9. PubMed ID: 1415534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of somatostatin on glucose homeostasis in conscious long-fasted dogs.
    Stevenson RW; Steiner KE; Hendrick GK; Cherrington AD
    Am J Physiol; 1987 Oct; 253(4 Pt 1):E435-42. PubMed ID: 2889363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of the effects of selective increases in peripheral or portal insulin on hepatic glucose production in the conscious dog.
    Sindelar DK; Balcom JH; Chu CA; Neal DW; Cherrington AD
    Diabetes; 1996 Nov; 45(11):1594-604. PubMed ID: 8866566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of glucagon on glucose production during insulin deficiency in the dog.
    Cherrington AD; Lacy WW; Chiasson JL
    J Clin Invest; 1978 Sep; 62(3):664-77. PubMed ID: 690190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extrapancreatic effect of somatostatin infusion to increase glucose clearance.
    Bergman RN; Ader M; Finegood DT; Pacini G
    Am J Physiol; 1984 Sep; 247(3 Pt 1):E370-9. PubMed ID: 6148014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of insulin on glucagon-stimulated glucose production in the conscious dog.
    Steiner KE; Williams PE; Lacy WW; Cherrington AD
    Metabolism; 1990 Dec; 39(12):1325-33. PubMed ID: 2246975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of acute glucagon removal on the metabolic response to stress hormone infusion in the conscious dog.
    McGuinness OP; Murrell S; Moran C; Bracy D; Cherrington AD
    Metabolism; 1994 Oct; 43(10):1310-7. PubMed ID: 7934986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of somatostatin on nonesterified fatty acid levels modifies glucose homeostasis during fasting.
    Hendrick GK; Frizzell RT; Cherrington AD
    Am J Physiol; 1987 Oct; 253(4 Pt 1):E443-52. PubMed ID: 2889364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extrapancreatic glucagon in control of glucose turnover in depancreatized dogs.
    Ross G; Lickley L; Vranic M
    Am J Physiol; 1978 Feb; 234(2):E213-19. PubMed ID: 623297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.